Boston Scientific treats 1st patient in Zero AF trial, aims for FDA win for Blazer catheter

Wed, 01/16/2013 - 4:11pm
Mass Device

Medical device giant Boston Scientific treats the 1st patient in a clinical trial of its Blazer open-irrigated temperature ablation catheter, hoping to use the results to win FDA clearance to treat patients with heart rhythm disorders.

Boston Scientific logo

Massachusetts medical device giant Boston Scientific (NYSE:BSX) launched a new study of its Blazer Open-Irrigated Temperature Ablation Catheter, hoping to use the results to win FDA approval.

The 1st patient was treated with the device, the latest in Boston Scientific's Blazer line and the company's 1st open-irrigated catheter, at St. David's Medical Center in Austin, Texas, by Dr. David Burkhardt, who said treatment with the new device was "consistent with my previous experience using other Boston Scientific Blazer catheters," according to a press release.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.